Akebia Therapeutics (AKBA) Amortization - Intangibles (2019 - 2024)

Akebia Therapeutics (AKBA) has 6 years of Amortization - Intangibles data on file, last reported at $9.0 million in Q4 2024.

• On a quarterly basis, Amortization - Intangibles changed 0.0% year-over-year to $9.0 million in Q4 2024; TTM through Sep 2025 was $9.0 million, a 75.0% decrease from a year earlier, with the FY2024 full-year figure at $36.0 million, changed 0.0% from the prior year.
• Amortization - Intangibles for Q4 2024 stood at $9.0 million, roughly flat from $9.0 million in the prior quarter.
• Over the last five years, Amortization - Intangibles for AKBA reached as high as $9.1 million in Q2 2020 and fell as low as $6.1 million in Q3 2020.
• Historically, Amortization - Intangibles has averaged $8.8 million across 5 years, with a median of $9.0 million in 2021.
• Across the five-year window, Amortization - Intangibles slumped 32.91% in 2020 and surged 47.58% in 2021, its largest moves.
• Year by year, Amortization - Intangibles stood at $8.3 million in 2020, then grew by 8.42% to $9.0 million in 2021, then changed by 0.0% to $9.0 million in 2022, then changed by 0.0% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $9.0 million in Q4 2024, $9.0 million in Q3 2024, and $9.0 million in Q2 2024.